Insiders who have reported open-market trades at the same companies as Dennis Matheis. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Dennis Matheis is a corporate insider, tracked as Director of DarioHealth Corp. (DRIO). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Dennis Matheis submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Dennis Matheis been buying or selling stock?
Recorded transactions: 3 open-market purchases ($447K) and 0 open-market sales across all tracked filings.
Dennis Matheis is Director of DarioHealth Corp. (DRIO). 6 SEC Form 4 filings on record going back to 2025, most recently on 28 September 2026. Most recent open-market trade: bought $100K of DRIO on 28 July 2026. Lifetime open-market purchases: $447K.
Recent transactions
7
The latest 7 SEC Form 4 transactions reported by Dennis Matheis.
InsiderAlpha's records for Dennis Matheis go back to 2025: 6 primary Form 4 filings, an average of 3.0 per year. The typical open-market purchase is $149K (3 buys totaling $447K). The largest single buy on record is $245K of LUCD in 2026. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
